Pentam and Botulism - a phase IV clinical study of FDA data

Summary:

Botulism is reported as a side effect among people who take Pentam (pentamidine isethionate), especially for people who are male, 20-29 old, also take Vancomycin, and have Clostridium difficile colitis.

The phase IV clinical study analyzes which people have Botulism when taking Pentam. It is created by eHealthMe based on reports of 5,677 people who have side effects when taking Pentam from the FDA, and is updated regularly.

What is Pentam?

Pentam has active ingredients of pentamidine isethionate. eHealthMe is studying from 5,686 Pentam users. Check the latest studies of Pentam.

What is Botulism?

Botulism (food poisoning caused by botulinum growing) is found to be associated with 21 drugs and 113 conditions by eHealthMe. Check the latest studies of Botulism.

On Jul, 19, 2026

5,677 people reported to have side effects when taking Pentam.
Among them, 11 people (0.19%) have Botulism.

Among these 11 people:

What is the gender of people who have Botulism when taking Pentam? *

female: 0.0 %
male: 100 %

What is the age of people who have Botulism when taking Pentam? *

What are other drugs people take besides Pentam? *

What are other side effects people have besides Botulism? *

Bacterial Toxaemia (blood contains bacterial toxins): 7 people, 63.64%
Drug Ineffective: 6 people, 54.55%
Brain Death: 4 people, 36.36%
Brain Herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull): 4 people, 36.36%
Bronchial Secretion Retention: 4 people, 36.36%
Cardiac Arrest: 4 people, 36.36%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 4 people, 36.36%
Unresponsive To Stimuli: 4 people, 36.36%
Vision Blurred: 3 people, 27.27%
Muscle Function Loss: 3 people, 27.27%

What are the existing conditions these people have? *

Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 9 people, 81.82%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 9 people, 81.82%
Immunodeficiency Disorders: 2 people, 18.18%
Ophthalmoplegia (a paralysis or weakness of one or more of the muscles that control eye movement): 1 person, 9.09%
Miller Fisher Syndrome (a rare disorder that is characterized by abnormal muscle coordination): 1 person, 9.09%
Infection: 1 person, 9.09%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 9.09%
Cytomegalovirus Infection: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Pentam and have Botulism?

- Check whether Botulism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pentam:

Pentam (5,686 reports)

Botulism treatments and more:

Botulism (703 reports)

Browse all side effects of Pentam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Botulism:

Botulism (21 drugs)

Browse all the conditions that are associated with Botulism:

Botulism (113 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pentamidine isethionate (the active ingredients of Pentam) and Pentam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.